Home > Insider Trading > Filing (0001140361-24-003663)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1220363	Md L Robert Zerbe	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-01-22	2,500	$41.39	28,395	No	4	S	Direct
Common Stock	Disposition	2024-01-22	2,500	$42.06	25,895	No	4	S	Direct
Common Stock	Acquisiton	2024-01-22	3,000	$4.12	28,895	No	4	M	Direct
Common Stock	Disposition	2024-01-22	3,000	$42.05	25,895	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2024-01-22	3,000	$0.00	3,000	$4.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.
These options, representing the right to purchase 3,000 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 7, 2014, which was one month after the date on which the option was granted.
These options, which were awarded on May 7, 2014, would otherwise expire and become forfeitable on May 7, 2024.